Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > Eden Rahim - Next Edge Capital

<< Previous

Bullboard Posts

Next >>

Post by FactFinder1994on Nov 24, 2020 7:53pm

826 Views

Post# 31966658

Eden Rahim - Next Edge Capital

Eden Rahim, of Next Edge Capital mentioned Microbix on BNN today and it shot up over 20% in last hour. MBX has a bright future!

Next Edge Capital also holds SQI Diagnostics in its portfolio (another Canadian Microcap), and although Eden did not directly mention SQI by name, he will be soon! Next Edge holds approximately 1% of SQI's float.

Exciting times ahead for MBX & SQI shareholders, and if you own these, you are in good company!

Stay tuned,

https://www.bnnbloomberg.ca/technology/video/countries-producing-vaccines-will-be-first-in-line-for-distribution-biotech-expert~2083982?jwsource=cl

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec